Ending Epidemics: Will the U.S. Continue to Lead?

TUE, JAN 30, 2018 (47:13)

There has been remarkable progress in global health over the last five decades, including eradication of smallpox, large scale treatment of AIDS, and dramatic reductions in childhood and maternal deaths. Through its foreign policy and foreign assistance, the U.S has lead in these and other health achievements, which have boosted life expectancy and economic development worldwide.

A healthier world has been both a gift to humankind and a benefit to the U.S. But will the U.S. continue to lead in addressing future global health challenges: making the world safer from pandemic threats, achieving universal health coverage, and confronting chronic diseases? Dr. Jonathan Quick, a Senior Fellow at Management Sciences for Health (MSH) and a faculty member at Harvard Medical School, is also international public health expert. He is the author of the forthcoming book, The End of Epidemics: The Looming Threat to Humanity and How to Stop It.

Photo: A U.S. Public Health officer in Monrovia, Liberia in 2014. By Sgt. 1st Class Nathan Hoskins.

+ BIO: Dr. Jonathan Quick

Jonathan D. Quick, MD, MPH, is Senior Fellow Emeritus at MSH, where he previously served as President and Chief Executive Officer from 2004-2017. In January of 2017 he transitioned to the role of Senior Fellow. A family physician and health management specialist, Dr. Quick focuses on global health security. Dr. Quick is the author of The End of Epidemics: The Looming Threat to Humanity and How to Stop It (forthcoming from St. Martin’s Press/Scribe in 2018). Dr. Quick was Director of Essential Drugs and Medicines Policy at the World Health Organization from 1996 to 2003. Prior to that, he served with MSH as founding director of the drug management program/center for pharmaceutical management, then as a long-term advisor for the Afghanistan Health Sector Support Project and the Kenya Health Care Financing Project. Dr. Quick has worked in international health since 1978 and has carried out assignments in over 70 countries in Africa, Asia, Latin America, and the Middle East. He is the senior editor of Managing Drug Supply, co-author of the Financial Times Guide to Executive Health; and has written over 100 other books, articles, and chapters. He is on the faculty of Harvard Medical School Department of Global Health and Social Medicine and Boston University School of Public Health, and is a Fellow of the Royal Society of Medicine. He has a first degree from Harvard University and an MD, with distinction in research, and masters of public health from the University of Rochester.

Navigating the COVID-19 Pandemic And Other Lessons in Disease